Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.

CONCLUSIONS: QOL is largely preserved in brain metastasis patients treated with SRS. Higher RPA class, upfront whole-brain radiation therapy, and greater intracranial disease burden are independent predictors of post-SRS QOL deterioration. Worse pre-SRS QOL predicts shorter survival. Assessment of QOL is recommended in brain metastasis patients managed with SRS. PMID: 32650308 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32650308?dopt=Abstract

Source: Journal of Neurosurgery - July 9, 2020 Category: Neurosurgery Authors: Bunevicius A, Lavezzo K, Shabo L, McClure J, Sheehan JP Tags: J Neurosurg Source Type: research